Jefferies Group’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-57,500
| Closed | -$10.6M | – | 2285 |
|
|
2021
Q2 | $10.6M | Buy |
57,500
+44,184
| +332% | +$7.58M | 0.18% | 263 |
|
|
2021
Q1 | $2.04M | Sell |
13,316
-72,472
| -84% | -$11.2M | 0.05% | 675 |
|
|
2020
Q4 | $13.4M | Buy |
85,788
+79,594
| +1,285% | +$10.2M | 0.29% | 162 |
|
|
2020
Q3 | $709K | Buy |
6,194
+4,983
| +411% | +$538K | 0.02% | 903 |
|
|
2020
Q2 | $136 | Sell |
1,211
-11,309
| -90% | -$1.2M | ﹤0.01% | 1096 |
|
|
2020
Q1 | $1.09M | Sell |
12,520
-44,395
| -78% | -$4.36M | 0.04% | 969 |
|
|
2019
Q4 | $6.16M | Buy |
56,915
+16,274
| +40% | +$1.74M | 0.11% | 427 |
|
|
2019
Q3 | $3.98M | Buy |
40,641
+31,686
| +354% | +$3.57M | 0.1% | 652 |
|
|
2019
Q2 | $1.17M | Buy |
8,955
+5,909
| +194% | +$762K | 0.03% | 1206 |
|
|
2019
Q1 | $412K | Sell |
3,046
-18,298
| -86% | -$2.28M | 0.01% | 1677 |
|
|
2018
Q4 | $2.08M | Buy |
21,344
+19,737
| +1,228% | +$2.33M | 0.07% | 801 |
|
|
2018
Q3 | $223K | Sell |
1,607
-71,762
| -98% | -$9M | 0.01% | 2056 |
|
|
2018
Q2 | $9.11M | Buy |
73,369
+65,383
| +819% | +$7.64M | 0.21% | 294 |
|
|
2018
Q1 | $890K | Buy |
+7,986
| New | +$955K | 0.02% | 1252 |
|
|
2017
Q4 | – | Sell |
-50,521
| Closed | -$7.09M | – | 2940 |
|
|
2017
Q3 | $7.09M | Buy |
50,521
+29,527
| +141% | +$4.01M | 0.17% | 401 |
|
|
2017
Q2 | $2.55M | Sell |
20,994
-36,439
| -63% | -$4.24M | 0.06% | 839 |
|
|
2017
Q1 | $6.96M | Buy |
+57,433
| New | +$7.4M | 0.17% | 375 |
|
|
2016
Q3 | – | Sell |
-34,441
| Closed | -$4.02M | – | 2592 |
|
|
2016
Q2 | $4.02M | Buy |
34,441
+29,797
| +642% | +$4.23M | 0.13% | 573 |
|
|
2016
Q1 | $647K | Sell |
4,644
-17,631
| -79% | -$2.59M | 0.02% | 1324 |
|
|
2015
Q4 | $4.25M | Sell |
22,275
-16,549
| -43% | -$2.89M | 0.13% | 544 |
|
|
2015
Q3 | $6.07M | Buy |
38,824
+6,787
| +21% | +$1.24M | 0.16% | 413 |
|
|
2015
Q2 | $5.79M | Buy |
+32,037
| New | +$5.53M | 0.13% | 462 |
|
|
2014
Q4 | – | Sell |
-5,116
| Closed | -$848K | – | 2544 |
|
|
2014
Q3 | $848K | Sell |
5,116
-5,227
| -51% | -$858K | 0.03% | 1081 |
|
|
2014
Q2 | $1.62M | Buy |
+10,343
| New | +$1.63M | 0.06% | 714 |
|
|
2014
Q1 | – | Sell |
-771
| Closed | -$102K | – | 2516 |
|
|
2013
Q4 | $102K | Sell |
771
-2,438
| -76% | -$293K | ﹤0.01% | 1698 |
|
|
2013
Q3 | $373K | Buy |
3,209
+2,959
| +1,184% | +$325K | 0.02% | 1335 |
|
|
2013
Q2 | $23K | Buy |
+250
| New | +$24.1K | ﹤0.01% | 1729 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM